NDC00074-7804-13: POTASSIUM CHLORIDE EXTENDED-RELE.
POTASSIUM CHLORIDE EXTENDED-RELE. Key specifications include special_features: EACH TABLET PROVIDES 10 MILLIEQUIVALENTS OF POTASSIUM, primary_container_type: BOTTLE, therapeutic_equivalent: K TAB BY ABBOTT LABS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-235-2629, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | EACH TABLET PROVIDES 10 MILLIEQUIVALENTS OF POTASSIUM |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | K TAB BY ABBOTT LABS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750 MG 100S |
| NSN | 6505-01-235-2629 |
| THERAPEUTIC EQUIVALENT | K TAB BY ABBOTT LABS |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | EACH TABLET PROVIDES 10 MILLIEQUIVALENTS OF POTASSIUM |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750 MG 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |